+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Tumor Embolization Devices Global Market Report 2020-30: COVID-19 Growth and Change

  • ID: 5185305
  • Report
  • November 2020
  • Region: Global
  • 200 pages
  • The Business Research Company
UP TO OFF
until Dec 31st 2020
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Angiodynamics
  • BTG Plc
  • Cook Meidical LLC
  • Medtronic plc
  • Merit Medical
  • Siemens Healthineers
  • MORE
Tumor Embolization Devices Global Market Report 2020-30: COVID 19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global tumor embolization devices market.

This report focuses on tumor embolization devices market which is experiencing strong growth. The report gives a guide to the tumor embolization devices market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the tumor embolization devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Tumor Embolization Devices market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider tumor embolization devices market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The tumor embolization devices market section of the report gives context. It compares the tumor embolization devices market with other segments of the tumor embolization devices market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, tumor embolization devices indicators comparison.
Scope

Markets Covered:
1) By Type: Radioembolic Agents; Non-radioactive Embolic Agents
2) By Application: Cancer Tumors; Noncancerous Tumors

Companies Mentioned: Boston Scientific Corporation; Medtronic plc; Terumo Corporation; Sirtex Medical Ltd; Merit Medical

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Angiodynamics
  • BTG Plc
  • Cook Meidical LLC
  • Medtronic plc
  • Merit Medical
  • Siemens Healthineers
  • MORE
1. Executive Summary

2. Tumor Embolization Devices Market Characteristics

3. Tumor Embolization Devices Market Size And Growth
3.1. Global Tumor Embolization Devices Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Tumor Embolization Devices Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Tumor Embolization Devices Market Segmentation
4.1. Global Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Radioembolic Agents
  • Non-radioactive Embolic Agents
4.2. Global Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Caner Tumors
  • Noncancerous Tumors
5. Tumor Embolization Devices Market Regional And Country Analysis
5.1. Global Tumor Embolization Devices Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Tumor Embolization Devices Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Tumor Embolization Devices Market
6.1. Asia-Pacific Tumor Embolization Devices Market Overview
6.2. Asia-Pacific Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Tumor Embolization Devices Market
7.1. China Tumor Embolization Devices Market Overview
7.2. China Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Tumor Embolization Devices Market
8.1. India Tumor Embolization Devices Market Overview
8.2. India Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Tumor Embolization Devices Market
9.1. Japan Tumor Embolization Devices Market Overview
9.2. Japan Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Tumor Embolization Devices Market
10.1. Australia Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Tumor Embolization Devices Market
11.1. Indonesia Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Tumor Embolization Devices Market
12.1. South Korea Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Tumor Embolization Devices Market
13.1. Western Europe Tumor Embolization Devices Market Overview
13.2. Western Europe Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Tumor Embolization Devices Market
14.1. UK Tumor Embolization Devices Market Overview
14.2. UK Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Tumor Embolization Devices Market
15.1. Germany Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Tumor Embolization Devices Market
16.4. France Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Tumor Embolization Devices Market
17.1. Eastern Europe Tumor Embolization Devices Market Overview
17.2. Eastern Europe Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Tumor Embolization Devices Market
18.1. Russia Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Tumor Embolization Devices Market
19.1. North America Tumor Embolization Devices Market Overview
19.2. North America Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Tumor Embolization Devices Market
20.1. USA Tumor Embolization Devices Market Overview
20.2. USA Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Tumor Embolization Devices Market
21.1. South America Tumor Embolization Devices Market Overview
21.2. South America Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Tumor Embolization Devices Market
22.1. Brazil Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Tumor Embolization Devices Market
23.1. Middle East Tumor Embolization Devices Market Overview
23.2. Middle East Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Tumor Embolization Devices Market
24.1. Africa Tumor Embolization Devices Market Overview
24.2. Africa Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Tumor Embolization Devices Market Competitive Landscape And Company Profiles
25.1. Tumor Embolization Devices Market Competitive Landscape
25.2. Tumor Embolization Devices Market Company Profiles
25.2.1. Boston Scientific Corporation
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Medtronic plc
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Terumo Corporation
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Sirtex Medical Ltd
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Merit Medical
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Tumor Embolization Devices Market

27. Tumor Embolization Devices Market Trends And Strategies

28. Tumor Embolization Devices Market Future Outlook and Potential Analysis

29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Angiodynamics
  • BTG Plc
  • Cook Meidical LLC
  • Medtronic plc
  • Merit Medical
  • Siemens Healthineers
  • MORE
Major players in the tumor embolization devices market are Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Sirtex Medical Ltd, Merit Medical, Cook Meidical LLC, BTG Plc, Angiodynamics and Siemens Healthineers.

The global tumor embolization devices market is expected to decline from $1.45 billion in 2019 to $1.36 billion in 2020 at a compound annual growth rate (CAGR) of -6.24%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $1.82 billion in 2023 at a CAGR of 10.22%.

The tumor embolization devices market consists of sales of tumor embolization devices and related services by entities (organizations, sole traders and partnerships) that manufacture tumor embolization devices. Tumor embolization devices are minimally invasive devices used in the treatment of tumors. These devices are used either to shut down the supply of blood to the tumor or to deliver tumor-killing therapy directly to the tumor. Only goods and services traded between entities or sold to end consumers are included.

North America was the largest region in the tumor embolization devices market in 2019.

The tumor embolization devices market covered in this report is segmented by type into radioembolic agents; non-radioactive embolic agents and by application into cancer tumors; noncancerous tumors.

In July 2019, Varian Medical Systems announced its decision to acquire Boston Scientific's portfolio of microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors for $90 million. Boston Scientific portfolio's acquisition is expected to strengthen Varian's product portfolio and market reach. Boston Scientific Corporation is a US-based company involved in the development, manufacture, and marketing of medical devices used in interventional medical specialties.

Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to advanced therapies and advanced therapy medicinal products. These regulations include changes to equipment approval procedures and other aspects. For instance, the United States Food and Drug Administration is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the tumor embolization devices market.

Companies in the tumor embolization devices market are increasingly investing in technological advances to provide more efficient devices to the consumers. The advances include the emergence of biocompatible, biodegradable, drug-eluting microspheres that provide effective embolization. Bioresorbable microspheres block the blood vessels causing tumors without long-term blockage of the healthy tissue blood vessels. In 2019, QXMédical announced its decision to license bioresorbable embolic technology from the University of Minnesota, to be used in tumor embolization devices for cancer and tumor treatment.

The rise in the number of cancer cases across the globe is likely to contribute to the growth of the tumor embolization devices market during the forecast period. According to the American Cancer Society, there were about 1.8 million new cases and 606,880 cancer deaths in 2019 in the USA. The four most common types of cancers worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all the new cancer cases. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for the tumor embolization market over the forthcoming years.
Note: Product cover images may vary from those shown
4 of 5
  • Boston Scientific Corporation
  • Medtronic plc
  • Terumo Corporation
  • Sirtex Medical Ltd
  • Merit Medical
  • Cook Meidical LLC
  • BTG Plc
  • Angiodynamics
  • Siemens Healthineers
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll